\-\ Texto\\:\\ \ \(0\)\
\-\ there\\ are\\ multiple\\ firm\\ hyperpigmented\\ indurated\\,\\ bound\\ down\\ plaques\\ extending\\ from\\ bilateral\\ inner\\ thighs\\ to\\ bilateral\\ shins\\.\\ \\ \ \(0\)\
\-\ no\\ lab\\ work\\ available\\.\ \(0\)\
\-\ no\\ treatment\\.\ \(2\)\
\-\ biopsy\\:\\ there\\ is\\ a\\ mild\\ perivascular\\ lymphocytic\\ infiltrate\\ with\\ increased\\ density\\ of\\ collagen\\ bundles\\ in\\ the\\ reticular\\ dermis\\.\\ \\ capillaries\\ are\\ reduced\\ in\\ number\\ with\\ atrophy\\ of\\ eccrine\\ glands\\.\ \(0\)\
\-\ nephrogenic\\ fibrosing\\ dermopathy\\/nephrogenic\\ systemic\\ fibrosis\ \(0\)\
\-\ 54\\ yo\\ woman\\ with\\ idiopathic\\ end\\-stage\\ renal\\ disease\\ for\\ four\\ years\\ requiring\\ renal\\ dialysis\\.\\ \\ she\\ presents\\ now\\ with\\ extensive\\ dry\\ and\\ firm\\ areas\\ that\\ started\\ on\\ both\\ anterior\\ shins\\ and\\ rapidly\\ progressed\\ to\\ involve\\ both\\ inner\\ thighs\\,\\ over\\ the\\ past\\ 3\\ months\\.\\ \\ she\\ also\\ complains\\ of\\ some\\ tenderness\\ of\\ the\\ lesions\\ to\\ palpation\\.\\ \\ \ \(0\)\
\-\ pmh\\:\\ six\\ previous\\ gadolinium\\ mr\\ scans\\.\\ \\ \\ \\ \\ \ \(0\)\
\-\ unremarkable\\ family\\ history\\.\ \(0\)\
\-\ nephrogenic\\ fibrosing\\ dermopathy\\ \\(nfd\\)\\ is\\ a\\ rare\\,\\ acquired\\,\\ idiopathic\\ disorder\\ in\\ patients\\ with\\ end\\-stage\\ renal\\ disease\\.\\ \\ clinically\\,\\ patient\\ typically\\ presents\\ with\\ large\\ area\\ of\\ indurated\\,\\ thick\\,\\ sclerotic\\ skin\\ involving\\ the\\ extremities\\.\\ \\ muscle\\ weakness\\ and\\ flexion\\ contractures\\ are\\ also\\ common\\.\\ \\ histologic\\ evaluation\\ reveals\\ increased\\ dermal\\ fibroblasts\\ and\\ elastic\\ fibers\\,\\ with\\ thick\\ collagen\\ bundles\\ and\\ mucin\\ deposition\\.\\ \\ \ \(0\)\
\-\ the\\ pathophysiology\\ of\\ nfd\\ is\\ not\\ known\\.\\ \\ most\\ patients\\ have\\ a\\ history\\ of\\ end\\-stage\\ renal\\ disease\\ requiring\\ hemodialysis\\.\\ \\ most\\ recently\\,\\ there\\ have\\ been\\ reports\\ of\\ nfd\\ associated\\ with\\ previous\\ gadolinium\\ mra\\ scans\\.\\ \\ also\\,\\ there\\ are\\ reported\\ cases\\ following\\ peritoneal\\ dialysis\\,\\ renal\\ transplantation\\,\\ and\\ acute\\ and\\ chronic\\ renal\\ disease\\.\ \(0\)\
\-\ case\\ presented\\ by\\ yang\\ xia\\,\\ m\\.d\\.\\,\\ cpt\\,\\ mc\\,\\ usa\\ at\\ the\\ 2007\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ san\\ antonio\\,\\ tx\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nfd\\:\\ 0\\.2929692165875973\ \(0\)\
\-\ nephrogenic\\:\\ 0\\.24466585372316985\ \(0\)\
\-\ renal\\:\\ 0\\.22816181896899396\ \(0\)\
\-\ dermopathy\\:\\ 0\\.1953128110583982\ \(0\)\
\-\ shins\\:\\ 0\\.18663181796243533\ \(0\)\
\-\ fibrosing\\:\\ 0\\.15695130652705022\ \(0\)\
\-\ indurated\\:\\ 0\\.1552375950909708\ \(0\)\
\-\ thighs\\:\\ 0\\.1536509461247405\ \(0\)\
\-\ bundles\\:\\ 0\\.14827031343108735\ \(0\)\
\-\ dialysis\\:\\ 0\\.13529296810398678\ \(0\)\
\-\ collagen\\:\\ 0\\.1239704346893554\ \(0\)\
\-\ requiring\\:\\ 0\\.12179127093660803\ \(0\)\
\-\ inner\\:\\ 0\\.11950100177972373\ \(0\)\
\-\ thick\\:\\ 0\\.11606807152146904\ \(0\)\
\-\ firm\\:\\ 0\\.11071682793789311\ \(0\)\
\-\ scans\\:\\ 0\\.10627127675224289\ \(0\)\
\-\ idiopathic\\:\\ 0\\.10330808809511993\ \(0\)\
\-\ disease\\:\\ 0\\.10253185605521127\ \(0\)\
\-\ gadolinium\\:\\ 0\\.1017630927671827\ \(0\)\
\-\ xia\\:\\ 0\\.0976564055291991\ \(0\)\
\-\ there\\:\\ 0\\.09719047174350003\ \(0\)\
\-\ with\\:\\ 0\\.09565849642900454\ \(0\)\
\-\ of\\:\\ 0\\.0956013746304434\ \(0\)\
\-\ bound\\:\\ 0\\.09331590898121767\ \(0\)\
\-\ are\\:\\ 0\\.09268572877032812\ \(0\)\
\-\ previous\\:\\ 0\\.09228412047537404\ \(0\)\
\-\ contractures\\:\\ 0\\.09023627767035282\ \(0\)\
\-\ and\\:\\ 0\\.08832850220539015\ \(0\)\
\-\ eccrine\\:\\ 0\\.0878475300449338\ \(0\)\
\-\ also\\:\\ 0\\.08616983362160223\ \(0\)\
\-\ cpt\\:\\ 0\\.08424560092121654\ \(0\)\
\-\ hyperpigmented\\:\\ 0\\.08281614981150655\ \(0\)\
\-\ antonio\\:\\ 0\\.08281614981150655\ \(0\)\
\-\ fibroblasts\\:\\ 0\\.08155528457438994\ \(0\)\
\-\ elastic\\:\\ 0\\.08042740218608753\ \(0\)\
\-\ capillaries\\:\\ 0\\.07940710845882111\ \(0\)\
\-\ yang\\:\\ 0\\.07847565326352511\ \(0\)\
\-\ hemodialysis\\:\\ 0\\.0776187975454854\ \(0\)\
\-\ san\\:\\ 0\\.07608690563810609\ \(0\)\
\-\ mucin\\:\\ 0\\.07539602195266028\ \(0\)\
\-\ usa\\:\\ 0\\.07355636810318303\ \(0\)\
\-\ the\\:\\ 0\\.07310821325793497\ \(0\)\
\-\ she\\:\\ 0\\.07270121078927522\ \(0\)\
\-\ perivascular\\:\\ 0\\.07248497651438882\ \(0\)\
\-\ dermal\\:\\ 0\\.07151112529668958\ \(0\)\
\-\ pathophysiology\\:\\ 0\\.07151112529668958\ \(0\)\
\-\ transplantation\\:\\ 0\\.07105552540467883\ \(0\)\
\-\ reticular\\:\\ 0\\.06979466016756224\ \(0\)\
\-\ dermis\\:\\ 0\\.06902969326835352\ \(0\)\
\-\ patients\\:\\ 0\\.06870492855915475\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.06866677777925981\ \(0\)\
\-\ histologic\\:\\ 0\\.0683157633271503\ \(0\)\
\-\ both\\:\\ 0\\.06810580987999844\ \(0\)\
\-\ tx\\:\\ 0\\.06701659757810495\ \(0\)\
\-\ increased\\:\\ 0\\.06604221607497832\ \(0\)\
\-\ bilateral\\:\\ 0\\.06563728744084016\ \(0\)\
\-\ infiltrate\\:\\ 0\\.06481295511220468\ \(0\)\
\-\ glands\\:\\ 0\\.06481295511220468\ \(0\)\
\-\ dry\\:\\ 0\\.06432628123127837\ \(0\)\
\-\ mc\\:\\ 0\\.0640909974378433\ \(0\)\
\-\ most\\:\\ 0\\.06356026523881293\ \(0\)\
\-\ progressed\\:\\ 0\\.06341466845438769\ \(0\)\
\-\ fibers\\:\\ 0\\.06179574369635533\ \(0\)\
\-\ plaques\\:\\ 0\\.06160956540950724\ \(0\)\
\-\ deposition\\:\\ 0\\.06160956540950724\ \(0\)\
\-\ seminar\\:\\ 0\\.061426569813827166\ \(0\)\
\-\ rapidly\\:\\ 0\\.06106970404609521\ \(0\)\
\-\ have\\:\\ 0\\.06101074437816283\ \(0\)\
\-\ uniformed\\:\\ 0\\.06089563546830402\ \(0\)\
\-\ mra\\:\\ 0\\.060389794202373816\ \(0\)\
\-\ 2007\\:\\ 0\\.060389794202373816\ \(0\)\
\-\ services\\:\\ 0\\.05990678076999222\ \(0\)\
\-\ dermatology\\:\\ 0\\.05975050088986186\ \(0\)\
\-\ acquired\\:\\ 0\\.058857902294994505\ \(0\)\
\-\ presents\\:\\ 0\\.05875094036688333\ \(0\)\
\-\ reduced\\:\\ 0\\.05857617599199225\ \(0\)\
\-\ atrophy\\:\\ 0\\.057772925702264534\ \(0\)\
\-\ 54\\:\\ 0\\.0575180331445732\ \(0\)\
\-\ peritoneal\\:\\ 0\\.057392827253358404\ \(0\)\
\-\ number\\:\\ 0\\.056215269686986286\ \(0\)\
\-\ pmh\\:\\ 0\\.055255973171277235\ \(0\)\
\-\ lab\\:\\ 0\\.05515450339103927\ \(0\)\
\-\ six\\:\\ 0\\.054855740325961425\ \(0\)\
\-\ systemic\\:\\ 0\\.05418943755066096\ \(0\)\
\-\ involve\\:\\ 0\\.05373768352959682\ \(0\)\
\-\ recently\\:\\ 0\\.05330422424871483\ \(0\)\
\-\ complains\\:\\ 0\\.053135638376121445\ \(0\)\
\-\ flexion\\:\\ 0\\.05187477313900485\ \(0\)\
\-\ disorder\\:\\ 0\\.051654044047559966\ \(0\)\
\-\ started\\:\\ 0\\.05143777443614823\ \(0\)\
\-\ sclerotic\\:\\ 0\\.05122578767402935\ \(0\)\
\-\ fibrosis\\:\\ 0\\.051156048133145976\ \(0\)\
\-\ clinically\\:\\ 0\\.05074689075070241\ \(0\)\
\-\ is\\:\\ 0\\.05016928612386006\ \(0\)\
\-\ work\\:\\ 0\\.04978759423499337\ \(0\)\
\-\ down\\:\\ 0\\.04960563549162314\ \(0\)\
\-\ four\\:\\ 0\\.04948602551358581\ \(0\)\
\-\ family\\:\\ 0\\.048041716689256574\ \(0\)\
\-\ reports\\:\\ 0\\.047484830860321445\ \(0\)\
\-\ extensive\\:\\ 0\\.04704980560786487\ \(0\)\
\-\ history\\:\\ 0\\.046660814594027655\ \(0\)\
\-\ reveals\\:\\ 0\\.046451091477113564\ \(0\)\
\-\ extremities\\:\\ 0\\.04640639420272098\ \(0\)\
\-\ rare\\:\\ 0\\.04609863226062305\ \(0\)\
\-\ to\\:\\ 0\\.045798472989792706\ \(0\)\
\-\ in\\:\\ 0\\.045573053000588844\ \(0\)\
\-\ skin\\:\\ 0\\.04542672664058921\ \(0\)\
\-\ weakness\\:\\ 0\\.04456674035324374\ \(0\)\
\-\ reported\\:\\ 0\\.04398202264537583\ \(0\)\
\-\ muscle\\:\\ 0\\.043360268339129246\ \(0\)\
\-\ typically\\:\\ 0\\.04286837560712955\ \(0\)\
\-\ biopsy\\:\\ 0\\.042804465079003706\ \(0\)\
\-\ involving\\:\\ 0\\.04277265233147602\ \(0\)\
\-\ now\\:\\ 0\\.041918240394217314\ \(0\)\
\-\ areas\\:\\ 0\\.04145897504020715\ \(0\)\
\-\ available\\:\\ 0\\.041430914783866145\ \(0\)\
\-\ extending\\:\\ 0\\.04140292788775612\ \(0\)\
\-\ palpation\\:\\ 0\\.041181628396328974\ \(0\)\
\-\ cases\\:\\ 0\\.04107267089932605\ \(0\)\
\-\ unremarkable\\:\\ 0\\.04093801526643711\ \(0\)\
\-\ density\\:\\ 0\\.040492456002016966\ \(0\)\
\-\ past\\:\\ 0\\.039748755524830315\ \(0\)\
\-\ no\\:\\ 0\\.039715358152830595\ \(0\)\
\-\ area\\:\\ 0\\.039558861735544966\ \(0\)\
\-\ known\\:\\ 0\\.03953536011981649\ \(0\)\
\-\ mr\\:\\ 0\\.039511909986310455\ \(0\)\
\-\ some\\:\\ 0\\.03842157250861902\ \(0\)\
\-\ tenderness\\:\\ 0\\.038295382658428884\ \(0\)\
\-\ yo\\:\\ 0\\.038150016949165484\ \(0\)\
\-\ years\\:\\ 0\\.037432095590442215\ \(0\)\
\-\ evaluation\\:\\ 0\\.03724093012359957\ \(0\)\
\-\ following\\:\\ 0\\.036633261595283316\ \(0\)\
\-\ chronic\\:\\ 0\\.03624650426634615\ \(0\)\
\-\ presented\\:\\ 0\\.035609713579600064\ \(0\)\
\-\ been\\:\\ 0\\.03557722499118925\ \(0\)\
\-\ months\\:\\ 0\\.03554483470425516\ \(0\)\
\-\ lesions\\:\\ 0\\.03507038563830064\ \(0\)\
\-\ common\\:\\ 0\\.034630912081274015\ \(0\)\
\-\ mild\\:\\ 0\\.03461607495947442\ \(0\)\
\-\ anterior\\:\\ 0\\.03409518932018313\ \(0\)\
\-\ over\\:\\ 0\\.033954886110447446\ \(0\)\
\-\ acute\\:\\ 0\\.033033890106667144\ \(0\)\
\-\ associated\\:\\ 0\\.03218589246250044\ \(0\)\
\-\ woman\\:\\ 0\\.031802909184732255\ \(0\)\
\-\ case\\:\\ 0\\.030678447464829187\ \(0\)\
\-\ large\\:\\ 0\\.030596651600473028\ \(0\)\
\-\ multiple\\:\\ 0\\.029868274545055213\ \(0\)\
\-\ treatment\\:\\ 0\\.02908855232763896\ \(0\)\
\-\ that\\:\\ 0\\.026499967900327596\ \(0\)\
\-\ by\\:\\ 0\\.025931787516150655\ \(0\)\
\-\ from\\:\\ 0\\.024252472980555558\ \(0\)\
\-\ not\\:\\ 0\\.02410705302059083\ \(0\)\
\-\ at\\:\\ 0\\.02306506528247918\ \(0\)\
\-\ patient\\:\\ 0\\.019861414892773127\ \(0\)\
\-\ for\\:\\ 0\\.018508366323432925\ \(0\)\
\-\ on\\:\\ 0\\.018442711522940074\ \(0\)\
